2 reports

  • Green Cross Corporation - Research and Development Overview
  • Green Cross Corporation - Company Statement

R& D Progress Research and Development Brief In Dec 2012, Legochem Bio announced that it has licensed out its ADC to Green Cross.

  • Research And Development
  • United States
  • World
  • Company Operations
  • Green Cross

R& D Progress Research and Development Brief Company reported that the drug candidate has demonstrated superior activity in tumors where PD-## monotherapy or PD-##/ LAG-## monoclonal antibody combo has shown activity.

  • Immunotherapy
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • MacroGenics, Inc.